目的:本研究通过非清髓性预处理方案联合髓腔内骨髓移植建立异基因小鼠免疫耐受模型,并探讨其诱导耐受的机理.方法:受鼠C57BL/6(B6)于第0天接受60Coγ射线全身照射(TBI,550-cGy),4 h内输注雄性BALB/C(H2d)小鼠来源的骨髓细胞,2 d后腹腔注射环磷酰胺(CTX,200 mg·kg-1).通过皮肤移植、混合淋巴细胞反应(mixed lymphocyte reaction, MLR)检测耐受状态,并应用体外过继转移实验、IL 2逆转实验等探讨免疫耐受机制.结果:经骨髓移植的B6小鼠对BALB/C小鼠的皮肤移植物平均存活时间超过300d,较空白组明显延长(P＜0.001);MLR结果证明B6小鼠获得供体特异性耐受,该耐受可以被IL 2逆转且可被过继转移;所有受鼠均未出现GVHD表现.结论:非清髓预处理联合髓腔内骨髓移植可以有效诱导异基因小鼠的免疫耐受.

[1] KUSHIDA T, INABA M, HISHA H. Intra-bone marrow injection of allogeneic bone marrow cells:a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice, 2001
[2] MAYUMI H, HIMEMO K, SKIN T. Drug-induced tolerance to allografts in mice, 1985
[3] ILDSTAD S T, WREN S M, OH E. Mixed allogeneic reconstitution (A+B→A) to induce donor-specific transplantation tolerance.Permanent acceptance of a simultaneous donor skin graft. 1991. doi:10.1097/00007890-199106000-00022
[4] ITABASHI Y, NARUMI S, HAKAMADA K. Allogeneic chimerism established with a mixture of low dose bone marrow cells and splenocytes in sublethally irradiated mice. 2002(1). doi:10.1016/S0966-3274(1)00046-6
[5] NAKAMURA K, INABA M, SUGIURA K. Enhancement of allogeneic hematopoietic stem cell engraftment and prevention of GVHD by intra-bone marrow bone marrow transplantation plus donor lymphocyte infusion. 2004. doi:10.1634/stemcells.22-2-125
[6] MAYUMI H, HIMENO K, TANAKA K. Drug-induced tolerance to allografts in mice.IX.Establishment of complete chimerism by allogeneic spleen cell transplantation from donors made tolerant to H-2-identical recipients. 1986. doi:10.1097/00007890-198610000-00018
[7] TOMITA Y, NISHIMURA Y, HARADA N. Evidence for involvement of clonal anergy in MHC class Ⅰ and class Ⅱ disparate skin allograft tolerance after the termination of intrathymic clonal deletion, 1990
[8] COLSON Y L, LI H, BOGGS S S. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach, 1996
[9] BACHAR L E, RACHAMIM N, LI H W. Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice. 1995. doi:10.1038/nm1295-1268
[10] OKAYAMA J, KO S, KANEHIRO H. Bone marrow chimerism and tolerance induced by single-dose cyclophosphamide. 2004(1). doi:10.1016/j.jss.2004.01.011
[11] SUGIURA K, KATO K, HASHIMOTO F. Induction of donor specific T cell anergy by portal venous injection of allogeneic cells. 1997
[12] KUSHIDA T, INABA M, TAKEUCHI K. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation. 2000
[13] PRIGOZHINA T, GUREVITCH O, SLAVIN S. Non-myeloablative conditioning to induce tolerance after allogeneic bone marrow transplantation in mice. 1999. doi:10.1016/S0301-472X(99)00088-0